The Latest Breaking News from CI

Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential.

Despite Cigna Group’s recent underperformance relative to the Dow, Wall Street analysts remain strongly optimistic about the stock’s prospects.

The healthcare industry thrives due to novel drug pipeline discoveries, AI integration to streamline processes and technological advancements. So, investing in undervalued healthcare stocks with upside potential, Pfizer (PFE), Cigna Group (CI), and Centene Corp (CNC), could be a wise idea. Keep reading….

Cigna Group has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

Cigna Group is set to announce its fiscal third-quarter earnings next week, and analysts anticipate a modest single-digit profit increase.

Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.

UnitedHealth will release its third-quarter earnings this month, and analysts anticipate a single-digit bottom-line growth.

Investing in growth stocks is appealing due to attractive pricing, stable business activity, easing inflation, and the Fed's gradual rate cuts, all of which create a favorable environment for capital gains. With a positive global economic outlook, it could be wise to consider investing in stocks that Wall Street loves…

With rising medical costs and an expanding aging population, the health insurance sector is set to witness significant growth. Hence, investors looking to capitalize on this trend could consider stable health insurance stocks Elevance Health (ELV), Cigna Group (CI), and Centene (CNC). Read on….

The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.